Neurocrine Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of NBIX for the last quarter is 622.10 M USD, and it's 5.40% higher compared to the previous quarter. The net income of Q3 24 is 129.80 M USD.